JAK-STAT signaling pathway

The pathway begins when a cytokine binds to its receptor, causing receptor dimerization and bringing associated JAKs into proximity. JAKs phosphorylate each other and the receptor, creating docking sites for STAT proteins. STATs bind via SH2 domains, are phosphorylated on a conserved tyrosine, then dimerize and translocate to the nucleus, where they bind DNA response elements to modulate transcription.¹

Negative regulation is critical: suppressors of cytokine signaling (SOCS) inhibit JAK activity, protein tyrosine phosphatases (e.g., SHP-1) dephosphorylate components, and protein inhibitors of activated STATs (PIAS) block STAT function. This ensures signal termination and prevents uncontrolled inflammation.²

JAK-STAT signaling is indispensable for immune function: interferons activate STAT1 to drive antiviral responses, while interleukins such as IL-6 activate STAT3 to promote inflammation and cell survival. In hematopoiesis, erythropoietin and thrombopoietin signals through JAK2 are essential for red blood cell and platelet production.³

Growth hormone and prolactin also use JAK2-STAT5, influencing growth and lactation. The pathway is tightly regulated; its constitutive activation is a hallmark of many cancers, including myeloproliferative neoplasms driven by the JAK2 V617F mutation.⁴

Dysregulated JAK-STAT signaling is implicated in autoimmune diseases, chronic inflammation, and malignancies. The JAK2 V617F mutation is found in most polycythemia vera cases and many essential thrombocythemia and primary myelofibrosis patients.⁴

JAK inhibitors (jakinibs) such as ruxolitinib and tofacitinib are approved for myelofibrosis, rheumatoid arthritis, and other conditions. These drugs block ATP binding in JAKs, reducing cytokine signaling. However, they can cause immunosuppression, and next-generation selective inhibitors are under development to improve safety.⁵

Beyond canonical signaling, STATs have non-transcriptional roles: mitochondrial STAT3 modulates electron transport chain activity and reactive oxygen species production, influencing cellular metabolism and apoptosis.⁶

Unconventional JAK-STAT functions include regulation of chromatin structure via histone modifications and DNA methylation. Additionally, the pathway is exploited by pathogens: viruses like hepatitis C and bacteria like Mycobacterium tuberculosis hijack or suppress JAK-STAT to evade immune responses.⁷

In development, JAK-STAT is critical for Drosophila segmentation and eye development, highlighting its evolutionary conservation from insects to mammals.⁸

Cytokine

A small protein released by cells that affects the behavior of other cells, often involved in immune signaling.

JAK

Janus kinase, a family of intracellular tyrosine kinases that associate with cytokine receptors.

STAT

Signal transducer and activator of transcription, a family of transcription factors that mediate cytokine responses.

SH2 domain

A protein domain that binds phosphorylated tyrosine residues, mediating protein-protein interactions.

SOCS

Suppressor of cytokine signaling, a family of proteins that inhibit JAK-STAT signaling.